Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging
Clinical trial NCT04137263 · COMPLETED
Trial details
- NCT number
- NCT04137263
- Sponsor
- Goldman, Butterwick, Fitzpatrick and Groff
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-01
- Primary completion
- 2020-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.